[Hyperprolactinemia secondary to hypotensive treatment with verapamil].
Ortega Calvo
M
M
Macías Pérez
V
V
Merino Kolly
M N
MN
Torelló Iserte
J
J
D000328:Adult; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects*; D014700:Verapamil / Q000009:adverse effects*
D014665:Vasodilator Agents; D014700:Verapamil